Optimization of Theophylline Delayed Release Dosage Form Using D-Optimal Experimental Design
Published in June 2015 Issue 3 (Vol. 5, Issue 3, 2015)

Abstract
Authors (3)
Yasser El-Malah
Department of Pharmaceutics, C...Department of Pharmaceutics, College of Pharmacy, ...Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura Universi...Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura University, Makkah, KSA
View all publications →Asim Y. Ibrahim
Department of Pharmaceutics, C...Department of Pharmaceutics, College of Pharmacy, ...Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura Universi...Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura University, Makkah, KSA
View all publications →Mohamed A.S. Abourehab
Department of Pharmaceutics, C...Department of Pharmaceutics, College of Pharmacy, ...Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura Universi...Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura University, Makkah, KSA
View all publications →Download Article
Best for printing and citation
Download Article
Best for printing and citation
Article Information
Published in:
June 2015 Issue 3 (Vol. 5, Issue 3, 2015)AJPTR53025
AJPTR-01-001933
2015-06-01
Article Impact
How to Cite
El-Malah & Y., A. & A.S., M. (2015). Optimization of Theophylline Delayed Release Dosage Form Using D-Optimal Experimental Design. American Journal of PharmTech Research, 5(3), xx-xx. https://ajptr.com/articles/AJPTR53025
Article Actions
More from this Issue
Concept of Contraception in Unani System of Medicine: Contemporary Research and Application
A Review on Phytoconstituent Analysis by Different Analytical Techniques
Curcumin Metallocomplexes: Reexploring Therapeutic Potential of Curcumin
More by These Authors
In Vitro Evaluation of Anticancer Activity of Sorgamara Ilai Chooranam (Leaves of Simarouba Glauca) Against A549 Cell Line (Human Lung Cancer Cell)
2018 • Vol. 8, Issue 6
Read more →